Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Depreciation and Depletion: 2011-2017

Historic Depreciation and Depletion for Prestige Consumer Healthcare (PBH) over the last 6 years, with Mar 2017 value amounting to $1.7 million.

  • Prestige Consumer Healthcare's Depreciation and Depletion rose 13.33% to $1.7 million in Q1 2017 from the same period last year, while for Mar 2017 it was $6.0 million, marking a year-over-year increase of 15.38%. This contributed to the annual value of $9.7 million for FY2025, which is 18.29% up from last year.
  • Prestige Consumer Healthcare's Depreciation and Depletion amounted to $1.7 million in Q1 2017, which was up 30.77% from $1.3 million recorded in Q4 2016.
  • Prestige Consumer Healthcare's 5-year Depreciation and Depletion high stood at $1.7 million for Q1 2017, and its period low was $500,000 during Q3 2013.
  • Over the past 3 years, Prestige Consumer Healthcare's median Depreciation and Depletion value was $1.3 million (recorded in 2016), while the average stood at $1.4 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first skyrocketed by 500.00% in 2013, then declined by 9.09% in 2014.
  • Over the past 5 years, Prestige Consumer Healthcare's Depreciation and Depletion (Quarterly) stood at $1.1 million in 2013, then dropped by 9.09% to $1.0 million in 2014, then grew by 20.00% to $1.2 million in 2015, then rose by 8.33% to $1.3 million in 2016, then climbed by 13.33% to $1.7 million in 2017.
  • Its last three reported values are $1.7 million in Q1 2017, $1.3 million for Q4 2016, and $1.5 million during Q3 2016.